참고문헌
- Carvalho IN, Reis AH, Cabello PH, et al (2013). Polymorphisms of CDKN1A gene and risk of retinoblastoma. Carcinogenesis, 34, 2774-7. https://doi.org/10.1093/carcin/bgt308
- Derynck R, Akhurst RJ, Balmain A (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat Genet, 29, 117-29. https://doi.org/10.1038/ng1001-117
- Driver KE, Song H, Lesueur F, et al (2008). Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis, 29, 333-41. https://doi.org/10.1093/carcin/bgm284
- Englert C, Maheswaran S, Garvin AJ, et al (1997). Induction of p21 by the Wilms’ tumor suppressor gene WT1. Cancer Res, 57, 1429-34.
- Gartel AL (2005). The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res, 29, 1237-8. https://doi.org/10.1016/j.leukres.2005.04.023
- Gartel AL, Tyner AL (2002). The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther, 1, 639-49.
- Guo W, Cui YJ, Fang SM, et al (2006). [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Ai Zheng, 25, 194-9.
- Jiang M, Shao ZM, Wu J, et al (1997). p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis. Int J Cancer, 74, 529-34. https://doi.org/10.1002/(SICI)1097-0215(19971021)74:5<529::AID-IJC9>3.0.CO;2-5
- Lei D, Sturgis EM, Liu Z, et al (2010). Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis, 31, 222-7. https://doi.org/10.1093/carcin/bgp279
- Li G, Liu Z, Sturgis EM, et al (2005). Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 26, 1596-602. https://doi.org/10.1093/carcin/bgi105
- Li R, Waga S, Hannon GJ, et al (1994). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature, 371, 534-7. https://doi.org/10.1038/371534a0
- Liu B, Zhang Y, Jin M, et al (2010). Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog, 49, 75-84.
- Liu F, Wei YG, Luo LM, et al (2013). Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study. Int J Cancer, 132, 2056-64. https://doi.org/10.1002/ijc.27885
- Liu S, Bishop WR, Liu M (2003). Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat, 6, 183-95. https://doi.org/10.1016/S1368-7646(03)00044-X
- Ma H, Jin G, Hu Z, et al (2006). Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Int J Cancer, 119, 2173-8. https://doi.org/10.1002/ijc.22094
- Polakova V, Pardini B, Naccarati A, et al (2009). Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat, 30, 661-8. https://doi.org/10.1002/humu.20931
- Roninson IB (2002). Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett, 179, 1-14. https://doi.org/10.1016/S0304-3835(01)00847-3
- Shao A, Zheng L, Chen S, et al (2014). p21, p53, TP53BP1 and p73 polymorphisms and the risk of gastric cardia adenocarcinoma in a Chinese population. Biomarkers, 1-7.
- Sherr CJ (1996). Cancer cell cycles. Science, 274, 1672-7. https://doi.org/10.1126/science.274.5293.1672
- Sivonova MK, Vilckova M, Jurecekova J, et al (2013). The role of p21 3'UTR gene polymorphism in the risk of prostate cancer: a pilot study. Mol Med Rep, 7, 986-90. https://doi.org/10.3892/mmr.2012.1242
- Suzuki H, Ito R, Ikeda K, et al (2012). TATA-binding protein (TBP)-like protein is required for p53-dependent transcriptional activation of upstream promoter of p21Waf1/Cip1 gene. J Biol Chem, 287, 19792-803. https://doi.org/10.1074/jbc.M112.369629
- Taghavi N, Biramijamal F, Abbaszadegan MR, et al (2010). P21(waf1/cip1) gene polymorphisms and possible interaction with cigarette smoking in esophageal squamous cell carcinoma in northeastern Iran: a preliminary study. Arch Iran Med, 13, 235-42.
- Waga S, Li R, Stillman B (1997). p53-induced p21 controls DNA replication. Leukemia, 11, 321-3.
- Wakasugi E, Kobayashi T, Tamaki Y, et al (1997). p21(Waf1/Cip1) and p53 protein expression in breast cancer. Am J Clin Pathol, 107, 684-91. https://doi.org/10.1093/ajcp/107.6.684
- Wang N, Wang S, Zhang Q, et al (2012). Association of p21 SNPs and risk of cervical cancer among Chinese women. BMC Cancer, 12, 589. https://doi.org/10.1186/1471-2407-12-589
- Wu X, Gu J, Grossman HB, et al (2006). Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet, 78, 464-79. https://doi.org/10.1086/500848
- Xiong Y, Hannon GJ, Zhang H, et al (1993). p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-4. https://doi.org/10.1038/366701a0
- Yin D, Jiang Y, Zhang S, et al (2015). No association between p21 Gene rs1059234 polymorphisms and risk of endometrial cancer among han women in northeast China. Cell Biochem Biophys, 71, 167-71. https://doi.org/10.1007/s12013-014-0180-5
- Zheng L, Tang W, Shi Y, et al (2014). p21 rs3176352 G>C and p73 rs1801173 C>T polymorphisms are associated with an increased risk of esophageal cancer in a Chinese population. PLoS One, 9, 96958. https://doi.org/10.1371/journal.pone.0096958
피인용 문헌
- The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women vol.37, pp.9, 2016, https://doi.org/10.1007/s13277-016-5078-y